Angiodynamics Inc (NASDAQ: ANGO)

AngioDynamics is a dynamic, diversified medical technology company that designs, manufactures and sells products and technologies to aid clinicians in treating patients with cardiovascular disease and cancer diagnoses. The company focuses on innovative research and development, expanding clinical and regulatory pathways, and driving customer centric sales performance to improve treatment options and patient outcomes. It maintains a commitment to clinical evidence and physician collaboration to bring novel therapies to market.

AngioDynamics generates revenue primarily through the sale of its medical devices across two operating segments, Med Tech and Med Device. Its product portfolio includes atherectomy systems, thrombectomy devices, NanoKnife ablation platforms, angiographic catheters, guidewires, drainage catheters, micropuncture kits, implantable ports, venous insufficiency laser systems, microwave ablation units, and specialized balloons for radiation therapy. The company sells these products to hospitals, outpatient clinics, and other healthcare providers in the United States and internationally. It utilizes a direct sales force in the U. S. and a combination of direct sales and distributor relationships abroad.

The company operates through the following segments: Med Tech and Med Device.

• Med Tech: This segment includes the Auryon Atherectomy System for peripheral arterial disease, thrombectomy products such as the AlphaVac and AngioVac mechanical aspiration devices and thrombolytic catheters, and the NanoKnife Irreversible Electroporation ablation system for soft tissue and prostate tissue.

• Med Device: This segment comprises peripheral products like angiographic catheters, guidewires, drainage catheters, micropuncture kits; implantable ports including SmartPort, BioFlo and Xcela Plus families; port technologies such as BioFlo Endexo coating, Vortex design and PASV valve; venous insufficiency treatments via the VenaCure EVLT laser system; microwave ablation through the Solero MTA system; and specialized balloons like the IsoLoc endorectal and Alatus vaginal balloons for radiation therapy.

AngioDynamics competes in a highly competitive medical device market against large and specialized firms including Boston Scientific, Cook Medical, Medical Components (MedComp), Teleflex, Becton Dickinson, Medtronic, Merit Medical, Terumo, Johnson & Johnson, Philips Healthcare, Stryker, Penumbra, Varian Medical Systems, Abbott Laboratories and Total Vein Systems. The company believes its competitive advantages stem from product quality, clinical outcomes, ease of use, reliability, physician familiarity and cost effectiveness, which are increasingly important in an environment of cost conscious buyers and declining reimbursement rates. Ongoing investment in research and development supports its pipeline of next generation devices and helps sustain its market position.

AngioDynamics serves a broad base of healthcare providers, primarily hospitals, outpatient surgery centers, and specialty clinics. Its customers include interventional radiologists, interventional cardiologists, vascular surgeons, urologists, oncologists and critical care nurses who use the company’s devices in procedures ranging from vascular access and oncology to venous disease and radiation therapy. The company’s products are used in both inpatient hospital settings and outpatient procedure suites.